Review of therapeutic agents for the treatment of COVID-19

Abstract

In late December 2019, a cluster of unexplained pneumonia cases has been reported in Wuhan, China, named coronavirus disease 2019 (COVID -19) which has been spreading in 204 countries. In this review, the mains pharmaceutical option quoted previously and especially available for ICU patients are reviewed.

Description

Keywords

Citation

URI

Endorsement

Review

Supplemented By

Referenced By